Immune Escape Mechanisms in Intravascular Large B-Cell Lymphoma.

Nisha PatelGraham W SlackJuraj BodoSusana Ben-NeriahDiego R VillaLisa DurkinDaniel SochaChristian SteidlEric D Hsi

Published in: American journal of clinical pathology (2021)

Altogether, our data show that 65% (n = 20/31) of IVLBCLs may exploit immune evasion strategies through PD-L1/PD-L2 expression or downregulation of MHC proteins.

Keyphrases

diffuse large b cell lymphoma
coronary artery
cell proliferation
electronic health record
big data
artificial intelligence